Anti-mitochondrial antibodies (AMAs) directed against the E2 subunits of the 2-oxo acid dehydrogenase complexes (PDC-E2) represent the hallmark of PBC and can be confirmed in 90–95% of patients [16]. The gene discussed is DLAT; the disease is primary biliary cholangitis.